Voltas Faces GST Demands Totaling ₹4.34 Crores from Various Authorities
Voltas has received orders from GST authorities in Odisha, Punjab and Telangana, demanding a total of ₹4.34 crores in taxes, along with…
Clean Science Commercial Production of Hydroquinone and Catechol Commences
Clean Science and Technology Limited announces the commencement of commercial production of Hydroquinone (HQ) and Catechol. This milestone was…
EIH Limited Penalty Levied on Maidens Hotel for GST Non-Payment
EIH Limited has announced that a penalty of ₹57,98,473 has been levied on its Maidens Hotel by the Deputy Commissioner, Delhi. The penalty…
Poly Medicure Investor Meeting Scheduled for December 23, 2025
Poly Medicure has announced a schedule for an investor meeting to be held on December 23, 2025. The meeting will be conducted virtually and…
Granules India Board Meeting to Discuss Fundraising via Private Placement
Granules India has announced a board meeting scheduled for December 23, 2025, to discuss and evaluate proposals for raising funds. The company…
Fortis Healthcare Special Window for Re-lodgement of Physical Share Transfer Requests
Fortis Healthcare has announced a special window for re-lodgement of physical share transfer requests. This initiative follows SEBI guidelines…
Max Healthcare To Acquire Yerawada Properties and Build New Hospital in Pune
Max Healthcare plans to acquire 100% equity in Yerawada Properties Private Limited (YPPL) and establish a new ~450-bedded super speciality…
Max Healthcare To Acquire Yerawada Properties, Establish New Pune Hospital
Max Healthcare Institute Limited has announced its board’s approval to acquire 100% equity stake in Yerawada Properties Private Limited…
CEAT Subsidiary Name Change – CEAT Specialty Tyres B.V. to CEAT Tyres B.V.
CEAT has announced that the name of its wholly-owned subsidiary based in the Netherlands, formerly known as CEAT SPECIALTY TYRES B.V., has…
Alembic Pharmaceuticals Receives USFDA Approval for Travoprost Ophthalmic Solution
Alembic Pharmaceuticals has secured USFDA final approval for its Travoprost Ophthalmic Solution USP, 0.004% (Ionic Buffered Solution). This…